The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–262 of 262
Levy, F. O., Gudermann, T. W., Birnbaumer, M., Kaumann, A. J., & Birnbaumer, L. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80379-u · Cited by 72
5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study
Ashby, C. R., Minabe, Y., Edwards, E., & Wang, R. Y. (1991) · Brain Research · doi:10.1016/0006-8993(91)91316-s · Cited by 70
Garza, R. D. L., & Cunningham, K. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35331-5 · Cited by 70
Agonist‐Induced Phosphoinositide Hydrolysis in Choroid Plexus
Conn, P. J., & Sanders‐Bush, E. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13085.x · Cited by 69
Galloway, M. P., Suchowski, C. S., Keegan, M., & Hjorth, S. (1993) · Synapse · doi:10.1002/syn.890150109 · Cited by 66
Kankaanpää, A., Meririnne, E., & Seppαlä, T. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0939-4 · Cited by 65
Pehek, E. A. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199609)24:1<12::aid-syn2>3.0.co;2-j · Cited by 65
Self-citationTanda, G., Frau, R., & Chiara, G. D. (1995) · Psychopharmacology · doi:10.1007/bf02246048 · Cited by 65
Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner
Rammes, G., Eisensamer, B., Ferrari, U., Shapa, M., Gimpl, G., Gilling, K. E., Parsons, C. G., Riering, K., Hapfelmeier, G., Bondy, B., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001490 · Cited by 65
Millan, M. J., Gobert, A., Newman‐Tancredi, A., Audinot, V., Lejeune, F., Rivet, J., Cussac, D., Nicolas, J., Müller, O., & Lavielle, G. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37731-6 · Cited by 65
Beart, P. M., & McDonald, D. (1982) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1982.tb04801.x · Cited by 63
Bowers, B. J., Henry, M. B., Thielen, R. J., et al. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751625.x · Cited by 63
Matsumoto, M., Togashi, H., Mori, K., Ueno, K., Miyamoto, A., & Yoshioka, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00636-6 · Cited by 62
Deurwaerdère, P. D., L'hirondel, M., Bonhomme, N., Lucas, G., Chéramy, A., & Spampinato, U. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010195.x · Cited by 61
Doherty, M. D., & Pickel, V. M. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1147 · Cited by 60
Lucas, G., Matteo, V. D., Deurwaerdère, P. D., Porras, G., Martín‐Ruiz, R., Artigas, F., Esposito, E., & Spampinato, U. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01453.x · Cited by 60
Broocks, A., Meyer, T., George, A., Hillmer-Vogel, U., Meyer, D., Bandelow, B., Hajak, G., Bartmann, U., Gleiter, C. H., & Rüther, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00056-6 · Cited by 59
Rasmussen, K., Stockton, M. E., & Czachura, J. F. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90781-k · Cited by 58
Nicotinic receptors co-localize with 5-HT3 serotonin receptors on striatal nerve terminals
Nayak, S. V., Rondé, P., Spier, A. D., Lummis, S. C. R., & Nichols, R. A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00109-x · Cited by 58
Porras, G., Deurwaerdère, P. D., Moison, D., & Spampinato, U. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02512.x · Cited by 58
5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes
Sarhan, H., Cloëz-Tayarani, I., Massot, O., Fillion, M., & Fillion, G. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005321 · Cited by 57
Pierucci, M., Matteo, V. D., & Esposito, E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062208 · Cited by 57
Porras, G., Matteo, V. D., Deurwaerdère, P. D., Esposito, E., & Spampinato, U. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00212-5 · Cited by 56
Cervo, L., Rozio, M. G., Ekalle-Soppo, C. B., Carnovali, F., Santangelo, E., & SAMANIN, R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1145-8 · Cited by 55
Rodd, Z. A., McKinzie, D. L., Meléndez, R. I., Berry, N. S., Murphy, J. M., & McBride, W. J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1300-2 · Cited by 54
Atypical antipsychotics in bipolar depression: Neurobiological basis and clinical implications
Brugue, E., & Vieta, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.014 · Cited by 54
Deurwaerdère, P. D., Moison, D., Navailles, S., Porras, G., & Spampinato, U. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03174.x · Cited by 52
Serotonin‐1B receptor‐mediated inhibition of [3H]GABA release from rat ventral tegmental area slices
Yan, Q., & Yan, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00643.x · Cited by 50
Devaud, L. L., Hollingsworth, E. B., & Cooper, B. R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08461.x · Cited by 49
Hållbus, M., Magnusson, T., & Magnusson, O. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00178-x · Cited by 49
Terry, A. V., Buccafusco, J. J., & Bartoszyk, G. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2114-1 · Cited by 49
McNeish, C. S., Svingos, A. L., HITZEMANN, R. J., & Strecker, R. E. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90118-d · Cited by 49
David, V., Ségu, L., Buhot, M.-C., Ichaye, M., & Cazala, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1767-5 · Cited by 48
Ashby, C. R., Edwards, E., Harkins, K., & Wang, R. Y. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90519-0 · Cited by 47
Thorré, K., Ebinger, G., & Michotte, Y. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00337-0 · Cited by 47
Fox, S. H., & Brotchie, J. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00238-7 · Cited by 46
Sarhan, H., Grimaldi, B., Hen, R., & Fillion, G. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900163 · Cited by 44
SSRI treatment decreases prolactin and hyperthermic responses to mCPP
Quested, D. J., Sargent, P. A., & Cowen, P. J. (1997) · Psychopharmacology · doi:10.1007/s002130050406 · Cited by 43
Ball, K. T., & Rebec, G. V. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0038-z · Cited by 43
Role and localization of serotonin2 (S2)-receptor-binding sites: effects of neuronal lesions.
Leysen, J. E., Gompel, P. V., Verwimp, M., & Cj, N. (1983) · PubMed · Cited by 42
Conditioned place preference for cocaine is attenuated in mice over-expressing the 5-HT 3 receptor
Allan, A. M., Galindo, R., Chynoweth, J., Engel, S., & Savage, D. D. (2001) · Psychopharmacology · doi:10.1007/s002130100833 · Cited by 41
Luo, J. J., Wallace, W., Riccioni, T., Ingram, D. K., Roth, G. S., & Kusiak, J. W. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990301)55:5<600::aid-jnr7>3.0.co;2-# · Cited by 40
Cobb, W. S., & Abercrombie, E. D. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01546.x · Cited by 39
Zazpe, A., Artaiz, I., & del Rı́o, J. A. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17087.x · Cited by 39
Zacopride in Schizophrenia: A Single-blind Serotonin Type 3 Antagonist Trial
Faustman, W. O. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090079013 · Cited by 37
Szumlinski, K. K., Frys, K. A., & Kalivas, P. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300473 · Cited by 36
Leysen, J. E., Geerts, R., Gommeren, W., Verwimp, M., & Gompel, P. V. (1982) · PubMed · Cited by 35
Shi, W. X., Nathaniel, P., & Bunney, B. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10609-5 · Cited by 33
de Groote, L., Olivier, B., & Westenberg, H. G. M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02154-x · Cited by 32
Cameron, D., & Williams, J. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb01947.x · Cited by 32
Action of serotonin in the medial prefrontal cortex: Mediation by serotonin3‐like receptors
Ashby, C. R., Edwards, E., & Wang, R. Y. (1992) · Synapse · doi:10.1002/syn.890100103 · Cited by 29
5‐HT3receptor agonist induced carrier‐mediated release of dopamine in rat striatumin vivo
Santiago, M., Machado, A., & Cano, J. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16371.x · Cited by 28
Filip, M., Papla, I., Nowak, E., Czepiel, K., & Przegaliński, E. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02873-x · Cited by 28
Takeda, H., Tsuji, M., Ikoshi, H., Yamada, T., Masuya, J., Iimori, M., & Matsumiya, T. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.012 · Cited by 28
Pehek, E. A., & Bi, Y. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00040-7 · Cited by 27
Self-citationMatell, M. S., & King, G. R. (1997) · Psychopharmacology · doi:10.1007/s002130050235 · Cited by 27
Prisco, S., Pessia, M., Ceci, A., Borsini, F., & Esposito, E. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90089-m · Cited by 25
King, G. R., Xue, Z., Calvi, C. L., & Ellinwood, E. H. (1995) · Psychopharmacology · doi:10.1007/bf02246219 · Cited by 16
Chiara, G. D. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_10 · Cited by 13
Richter, J. A., Bare, D. J., Yu, H., Ghetti, B. F., & Simon, J. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010191.x · Cited by 10
Arnsten, A. F. T., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.362 · Cited by 6
Cornea-Hébert (1999) · doi:10.1002/(sici)1096-9861(19990628)409:2<187::aid-cne2>3.0.co;2-p
Cited by
Brisch, R., Saniotis, A., Wolf, R., Bielau, H., Bernstein, H.-G., Steiner, J., Bogerts, B., Braun, A. K., Jankowski, Z., Kumaritlake, J., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00047 · Cited by 517
Serotonin and dopamine: unifying affective, activational, and decision functions.
Cools, R., Nakamura, K., & Daw, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.121 · Cited by 464
Opponency revisited: competition and cooperation between dopamine and serotonin
Boureau, Y.-L., & Dayan, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.151 · Cited by 456
Serotonin in Affective Control
Dayan, P., & Huys, Q. J. M. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135607 · Cited by 381
Potkin, S. G., Kane, J. M., Correll, C. U., Lindenmayer, J.-P., Agid, O., Marder, S. R., Olfson, M., & Howes, O. D. (2020) · npj Schizophrenia · doi:10.1038/s41537-019-0090-z · Cited by 359
Metadata
- Authors
- Alex, K. D., & Pehek, E. A.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 113
- Issue
- 2
- Pages
- 296-320
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2016437478
- Cited by
- 658
- References
- 262
- FWCI
- 10.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.